中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 11
Nov.  2018
Turn off MathJax
Article Contents

Pathological features of hepatic vascular diseases and key points in differential diagnosis

DOI: 10.3969/j.issn.1001-5256.2018.11.005
Research funding:

 

  • Published Date: 2018-11-20
  • Hepatic vascular diseases are a group of heterogeneous diseases which affect blood circulation in the liver. Although hepatic vascular diseases have a low incidence rate, they remain an important cause of portal hypertension. Patients often develop these diseases at a younger age, and misdiagnosis and/or mistreatment may greatly reduce their life expectancy. A good understanding of clinical manifestations, imaging features, and pathological features of hepatic vascular diseases is of vital importance in clarifying diagnosis and developing reasonable treatment strategies. This article introduces the pathological features of common hepatic vascular diseases and key points in differential diagnosis.

     

  • loading
  • [1] European Association for the Study of the Liver. EASL Clinical practice guidelines:Vascular diseases of the liver[J]. J Hepatol, 2016, 64 (1) :179-202.
    [2] BURT AD, FERRELL LD, HUBSCHER SG. Mac Sween's pathology of the liver, seventh edition[M]. Philadelphia:Elsevier, Ltd, 2018:653-689.
    [3] SARIN SK, KHANNA R. Non-cirrhotic portal hypertension[J]. Clin Liver Dis, 2014, 18 (2) :451-476.
    [4] ROSKAMS T, BAPTISTA A, BIANCHI L, et al. Histopathology of portal hypertension:A practical guideline[J]. Histopathology, 2003, 42 (1) :2-13.
    [5] VERHEIJ J, SCHOUTEN JN, KOMUTA M, et al. Histological features in western patients with idiopathic non-cirrhotic portal hypertension[J].Histopathology, 2013, 62 (7) :1083-1091.
    [6] LIU X, WANG TL, XIANG CH, et al. Liver pathology in idiopathic portal hypertension[J]. Chin J Hepatol, 2007, 15 (5) :374-377. (in Chinese) 刘霞, 王泰龄, 项灿宏, 等.特发性门静脉高压的肝脏病理学分析[J].中华肝脏病杂志, 2007, 15 (5) :374-377.
    [7] GUIDO M, ALVES VAF, BALABAUD C, et al. Histology of portal vascular changes associated with idiopathic non-cirrhotic portal hypertension:Nomenclature and definition[J]. Histopathology, 2018.[Epub ahead of print]
    [8] WANG BE, ZHANG DF. Modern hepatology[M]. Beijing:Science Press, 2003:766-774. (in Chinese) 王宝恩, 张定凤.现代肝脏病学[M].北京:科学出版社, 2003:766-774.
    [9] GUIDO M, SARCOGNATO S, SACCHI D, et al. Pathology of idiopathic non-cirrhotic portal hypertension[J]. Virchows Arch, 2018, 473 (1) :23-31.
    [10] SAXENA R. Practical hepatic pathology:A diagnostic approach[M].Philadelphia:Saunders, 2011:443-454.
    [9] RUSH N, SUN H, NAKANISHI Y, et al. Hepatic arterial buffer response:pathologic evidence in non-cirrhotic human liver with extrahepatic portal vein thrombosis[J]. Mod Pathol, 2016, 29 (5) :489-499.
    [10] KNOCKAERT DC, ROBAEYS GK, COX EJ, et al. Suppurative pylethrombosis:A changing clinical picture[J]. Gastroenterology, 1989, 97 (4) :1028-1030.
    [11] SARIN SK, KAPOOR D. Non-cirrhotic portal fibrosis:Current concepts and management[J]. J Gastroenterol Hepatol, 2002, 17 (5) :526-534.
    [12] LISOVSKY M, KONSTAS AA, MISDRAJI J. Congenital extrahepatic portosystemic shunts (Abernethy malformation) :A histopathologic evaluation[J]. Am J Surg Pathol, 2011, 35 (9) :1381-1390.
    [13] HAO Y, HONG X, ZHAO X. Congenital absence of the portal vein associated with focal nodular hyperplasia of the liver and congenital heart disease (Abernethy malformation) :A case report and literature review[J]. Oncol Lett, 2015, 9 (2) :695-700.
    [14] HU GH, SHEN LG, YANG J, et al. Insight into congenital absence of the portal vein:is it rare?[J]. World J Gastroenterol, 2008, 14 (39) :5969-5979.
    [15] TSOKOS M, ERBERSDOBLER A. Pathology of peliosis[J]. Forensic Sci Int, 2005, 149 (1) :25-33.
    [16] IWATA T, ADACHI K, TAKAHASHI M. Peliosis hepatis mimicking malignant hypervascular tumors[J]. J Gastrointest Surg, 2017, 21 (6) :1095-1098.
    [17] ZAK FG. Peliosis hepatis[J]. Am J Pathol, 1950, 26 (1) :1-15.
    [18] KHALID SK, GARCIA-TSAO G. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia[J]. Semin Liver Dis, 2008, 28 (3) :247-258.
    [19] LECLER A, RONOT M, DURAND F, et al. Massive biliary necrosis as a complication of a hereditary hemorrhagic telangiectasia[J]. Eur J Gastroenterol Hepatol, 2015, 27 (4) :471-474.
    [20] TANAKA M, WANLESS IR. Pathology of the liver in BuddChiari syndrome:Portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules[J]. Hepatology, 1998, 27 (2) :488-496.
    [21] CAZALS-HATEM D, VILGRAIN V, GENIN P, et al. Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome:A study in 17 explanted livers[J]. Hepatology, 2003, 37 (3) :510-519.
    [22] Cooperative Group for Hepatic and Gall Diseases, Chinese Society of Gastroenterology, Chinese Medical Association. Expert consensus on diagnosis and treatment of quinazoline alkaloids-related sinusoidal obstruction syndrome (2017, Nanjing) [J]. J Clin Hepatol, 2017, 33 (9) :1627-1637. (in Chinese) 中华医学会消化病学分会肝胆疾病协作组.吡咯生物碱相关肝窦阻塞综合征诊断和治疗专家共识意见 (2017年, 南京) [J].临床肝胆病杂志, 2017, 33 (9) :1627-1637.
    [23] RUBBIA-BRANDT L. Sinusoidal obstruction syndrome[J]. Clin Liver Dis, 2010, 14 (4) :651-668.
    [24] KUMAR S, DELEVE LD, KAMATH PS, et al. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation[J]. Mayo Clin Proc, 2003, 78 (5) :589-598.
    [25] CELLI R, ZHANG X. Pathology of alcoholic liver disease[J]. J Clin Transl Hepatol, 2014, 2 (2) :103-109.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2128) PDF downloads(501) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return